Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction.
Despite recent advances in the design of hemoglobin (Hb)-based oxygen carriers (HBOCs), vasoconstriction, presumably caused by nitric oxide (NO) scavenging, vessel wall hyperoxygenation, and/or extravasation, has been identified as the principal road block hampering commercial development of HBOCs. This study was designed to analyze systemic and microvascular responses to the molecular mass and plasma concentration of tense (T)-state polymerized bovine Hb (PolybHb) solutions. Experiments were performed using the hamster window chamber model subjected to successive hypervolemic infusions of T-state PolybHb solutions. PolybHb plasma concentrations were evaluated, namely, 0.5, 1.0 and 1.5 g/dl, respectively. Infusion of PolybHb solutions with molecular mass >500 kDa elicited hypertension and vasoconstriction proportional to the plasma concentration and inversely proportional to the PolybHb cross-link density. However, two high-molecular mass PolybHb solutions, PolybHb(40:1)(high) PolybHb(50:1)(high), did not elicit vasoconstriction at all concentrations studied, whereas PolybHb(50:1)(high) only elicited moderate hypertension at the highest concentration studied. In contrast, infusion of PolybHb solutions with molecular mass <500 kDa elicited significant hypertension and vasoconstriction compared with PolybHb solutions with molecular mass >500 kDa that was proportional to the plasma concentration and inversely proportional to the PolybHb cross-link density. We present promising results for highly cross-linked T-state PolybHb solutions with molecular mass >500 kDa [PolybHb(40:1)(high) PolybHb(50:1)(high)], which supports the concept that HBOC size/molecular mass influences its proximity to the vascular endothelium and molecular diffusivity. The hemodynamics of HBOC within the plasma layer surrounding the abluminal side endothelium regulates NO production and consumption, vessel oxygen flux, and extravasation. Although mechanistically attractive, neither of these hypotheses can be directly tested in vivo and will require further investigation.
Cabrales
Pedro
P
La Jolla Bioengineering Institute, 505 Coast Boulevard South, Suite 405, La Jolla, CA 92037, USA. pcabrales@ucsd.edu
Sun
Guoyong
G
Zhou
Yipin
Y
Harris
David R
DR
Tsai
Amy G
AG
Intaglietta
Marcos
M
Palmer
Andre F
AF
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D001802:Blood Substitutes / Q000008:administration & dosage* / Q000737:chemistry*; D002417:Cattle; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D006454:Hemoglobins / Q000008:administration & dosage* / Q000737:chemistry*; D007261:Infusions, Intra-Arterial; D008970:Molecular Weight; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
D001802:Blood Substitutes; D006454:Hemoglobins